Results 171 to 180 of about 5,691,277 (301)

Cannabis policy hub.

Under international laws, cultivation, supply and possession of cannabis should be allowed only for ‘medical and scientific purposes’. In general, possession of the drug for personal use should be a crime, to deter use, and most countries make this ...

core  

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Dose response relationship of medical cannabis and symptom control in patients with pancreatic cancer: an analysis of the CANPAN trial. [PDF]

Oncologist
Gupta A, Lin K, Chrenka E, Gilmore G, Cowger J, Rak D, Zylla D.   +6 more
europepmc   +1 more source

Social work and medical students' perspectives on the use of cannabis as a medical intervention

, 2015
This study examined the attitudes and perceived risks regarding the use of cannabis as a medical intervention from the perspectives of emerging health service professionals, with special reference to the medical and the social work professions.
Cogswell, Jennifer Brooke
core  

Efficacy, effectiveness and safety of medical cannabis in PTSD: a scoping review. [PDF]

J Cannabis Res
Aviram J, Belobrov R, Grinapol S, Fruchter E.   +3 more
europepmc   +1 more source

Alcohol consumption and cognitive function: A systematic review and dose–response meta‐analysis of 20 cohort studies

Addiction, EarlyView.
Abstract Background and aims Amid ongoing debate on whether low‐to‐moderate alcohol consumption reduces cardiovascular risk, studies examining the association between alcohol consumption and cognitive function have reported inconsistent results. To quantitatively assess this association, we conducted a dose–response meta‐analysis of cohort studies ...
Sooyeun Choi, Youjin Je
wiley   +1 more source

Doubtful medical cannabis prescribing practices identified from 55 medical cannabis websites. [PDF]

Aust N Z J Psychiatry
Dawson D, Lim C, Leung J, Lorenzetti V, Gray A, Hall W, Stjepanović D.   +6 more
europepmc   +1 more source

Cannabis use disorder in patients prescribed medical cannabis—Should we consider prescription cannabis use disorder as a new diagnostic condition?

Addiction, EarlyView.
Abstract Background and Aims The introduction of prescribed medical cannabis in many parts of the world raises issues regarding how we conceptualise Cannabis Use Disorders (CUD). The Diagnostic Statistical Manual Version 5 (DSM5) provides a framework for ‘Prescription Cannabis Use Disorder’ (Pr‐CUD) when a person is using medical cannabis only‐as ...
Nicholas Lintzeris, Llewellyn Mills
wiley   +1 more source

Therapeutic Use of Medical Cannabis Beyond Pain Management in Physical Medicine and Rehabilitation. [PDF]

Arch Intern Med Res
Cameron A, Fraix MP, Agrawal DK.
europepmc   +1 more source

Prescribed pharmaceutical alternatives initiative coinciding with reductions in unregulated street opioid use among young people who use drugs: An interrupted time series analysis

Addiction, EarlyView.
Abstract Background and aims In British Columbia, Canada, an initiative was implemented in 2020 to reduce overdose mortality by prescribing pharmaceutical opioids (primarily hydromorphone) as a substitute for the toxic unregulated drug supply. This study estimated changes in the level and trend of unregulated opioid use and non‐prescribed hydromorphone
Erica McAdam, Mohammad Karamouzian, Michael John Milloy, Carmen Verdicchio, Eric C. Sayre, Kanna Hayashi, Thomas Kerr, Kora DeBeck   +7 more
wiley   +1 more source